When clinical trials struggle to recruit patients, the instinct is often to double down on recruitment through more outreach, more advertising, and more targeting.
But for rare and ultra-rare diseases, the real problem usually isn’t recruitment.
It’s awareness.
Many potential participants in rare disease trials don’t know a study exists. Worse, many don’t even know they have the condition being studied.
This is why traditional recruitment strategies—designed to identify and convert known patients—often fall short in rare disease research. Before recruitment can begin, the clinical research community must first solve a different challenge: helping patients, caregivers, and clinicians recognize the disease and understand that research opportunities exist.
The diagnostic odyssey
Rare disease patients often experience a prolonged struggle to reach a correct diagnosis, a journey commonly called the diagnostic odyssey. On average, patients with rare diseases wait 4–5 years for an accurate diagnosis, often receiving multiple incorrect diagnoses along the way. Some patients wait even longer. Studies estimate that nearly 40% of rare disease patients are misdiagnosed at least once before receiving the correct diagnosis.
For sponsors designing clinical trials, this creates a fundamental challenge. The patients a study needs may exist—but many of them remain undiagnosed, misdiagnosed, or disconnected from research networks.
Traditional recruitment strategies assume a defined patient population already exists. In rare disease research, that population often still needs to be identified and educated.
Recruitment vs. awareness: A different starting point
Most recruitment campaigns begin with a straightforward question: Who can enroll in this study?
In rare disease trials, the more important question is often: Who might have this condition—and how can we help them find research?
Traditional recruitment focuses on reaching patients who already know they have a disease and may be actively seeking treatment options. These strategies rely on targeted advertising, patient databases, and clinical networks to convert interest into enrollment.
Awareness and education campaigns serve a different purpose. They expand the potential patient population by helping individuals understand symptoms, encouraging diagnostic conversations, and connecting communities with clinical research opportunities.
This distinction matters. Industry data shows that up to 50% of clinical trials experience delays due to recruitment challenges, and nearly 20% fail to enroll a single patient. In rare disease trials, these risks are even higher because the patient population is so limited.
Awareness campaigns help ensure that when recruitment begins, the right patients know the opportunity exists.
Awareness and education require a different channel strategy
Awareness and education campaigns also require a different media strategy and creative approach than traditional digital patient recruitment.
Traditional recruitment campaigns typically focus on conversion. They target patients who already know their diagnosis and are actively searching for treatment options. Channel strategies often prioritize high-intent environments—such as condition-specific search queries, patient registries, and clinical trial listing sites—where the goal is to guide patients quickly toward screening and enrollment.
Awareness campaigns operate much earlier in the patient journey. Instead of focusing on immediate conversion, these campaigns focus on education, symptom recognition, and community engagement. The goal is to reach individuals who may not yet recognize their condition or understand that clinical research could be relevant to them.
As a result, awareness strategies often rely on a broader omnichannel media mix, including:
- Social media and patient communities
- Digital health platforms and educational content hubs
- Advocacy group partnerships
- Healthcare education channels
- Video and storytelling platforms
Creative formats also differ significantly. Recruitment campaigns typically use direct-response creative, such as eligibility-focused messaging and clear calls to action designed to drive screening and enrollment.
Awareness campaigns use educational and storytelling formats that help patients and caregivers understand symptoms, disease progression, and emerging research opportunities. These may include:
- Educational videos and patient stories
- Symptom awareness content
- Physician or expert explainers
- Interactive disease education tools
- Community-driven content shared through advocacy networks
These formats build understanding and trust, helping individuals recognize when research may be relevant to them.
| Dimension | Awareness & education campaigns | Traditional digital patient recruitment |
|---|---|---|
| Primary goal | Increase disease awareness and symptom recognition | Identify and enroll eligible patients |
| Patient stage | Patients may be undiagnosed or unaware of the condition | Patients already know their diagnosis |
| Key question | Who might have this condition? |
Who qualifies for this study? |
| Campaign focus | Education, trust building, community engagement |
Conversion, screening, enrollment |
| Channel strategy | Broad omnichannel engagement across patient communities and education platforms | High-intent channels such as search, patient registries, and trial listings |
| Typical channels | Social media, advocacy groups, digital health platforms, educational hubs, video platforms | Paid search, targeted digital ads, clinical trial databases, condition-specific websites |
| Creative formats | Educational content, symptom awareness, patient stories, physician explainers | Eligibility messaging, screening invitations, enrollment calls-to-action |
| Measurement of success | Awareness, engagement, educational reach, community growth | Referrals, screenings, enrollments |
| Role in trial lifecycle | Builds the patient community and prepares the ecosystem for research | Converts known patients into study participants |
Small populations, global reach
Rare diseases affect relatively small populations by definition. Yet collectively, they impact a significant portion of the global population.
More than 7,000 rare diseases have been identified worldwide, affecting an estimated 300 million people globally. However, most individual rare diseases affect only a very small number of patients, and ultra-rare diseases may impact only a few hundred individuals worldwide. These patients are often geographically dispersed, making it difficult to reach them through conventional recruitment channels.
Education campaigns allow researchers and sponsors to connect with patients across regions and countries. By working with patient advocacy organizations, digital communities, and specialist networks, sponsors can build broader awareness of both the disease and the research being conducted.
This global engagement is often essential to identifying enough participants to support a clinical trial.
The role of caregivers and community
Rare disease communities are often deeply interconnected. Patients and caregivers rely heavily on advocacy groups, peer networks, and specialist clinicians for information and support.
Caregivers frequently play a central role in medical decision-making, especially in pediatric rare diseases. In fact, many rare diseases affect children, and approximately 50% of rare disease patients are pediatric.
Recruitment strategies must therefore engage both patients and caregivers, addressing the practical and emotional considerations involved in participating in research.
Education campaigns allow sponsors and researchers to build trust within these communities and ensure that information about research opportunities reaches the people who need it most.
Educating healthcare providers matters too
Patients are not the only audience that benefits from awareness and education.
Many clinicians will encounter only a handful of rare disease cases in an entire career, making it easy to miss a diagnosis or overlook a relevant trial. Without targeted education, eligible patients may never be referred at all.
Education initiatives aimed at healthcare professionals can improve disease recognition, encourage referrals, and ensure that patients learn about research opportunities earlier in their care journey.
How SubjectWell approaches rare disease
At SubjectWell, rare disease awareness and education campaigns are built to help sponsors reach patients who fall outside traditional research networks. By pairing global patient reach with science-led strategies, these campaigns surface potential participants earlier in their diagnostic journey, before they would otherwise enter a recruitment funnel.
A key component of this approach is global, omnichannel engagement. Rare disease patients often search for information across many platforms—digital health communities, social media, advocacy organizations, healthcare providers, and patient support networks. Meeting patients across these channels increases the likelihood that someone who may have the condition will encounter relevant educational content wherever they happen to be searching.
Equally important is localization. Rare disease awareness campaigns must resonate across different countries, healthcare systems, and cultural contexts. SubjectWell develops full-service localized creative, ensuring that messaging reflects local language, patient experiences, and healthcare realities. The result is content that feels credible and relevant to patients and caregivers regardless of where they live.
Combined with SubjectWell’s global patient ecosystem and data-driven targeting, these awareness campaigns help sponsors identify patients earlier, support diagnostic pathways, and connect individuals with clinical research opportunities they might otherwise never discover.
For rare and ultra-rare diseases—where patient populations are small and widely dispersed—this type of awareness-driven approach can significantly expand the pool of potential participants and help ensure that clinical trials reach the patients who need them most.
Rethinking patient engagement in rare disease clinical trials
Rare and ultra-rare disease trials challenge many of the assumptions that underpin traditional patient recruitment. In these conditions, the issue is rarely a lack of recruitment tactics—it is a lack of visibility. Patients may remain undiagnosed, misdiagnosed, or simply unaware that clinical research exists as a potential pathway to new treatment options.
Addressing this challenge requires the industry to rethink where recruitment truly begins. For rare diseases, successful enrollment often starts long before a trial launches—with awareness, education, and community engagement that help patients, caregivers, and healthcare providers recognize the disease and understand the role research can play.
By expanding awareness and connecting patients to information, diagnosis, and research opportunities earlier, sponsors can build a stronger foundation for recruitment success. Ultimately, awareness-driven strategies do more than improve enrollment—they help ensure that research finds patients who need it, and that patients find the research that could change their lives.
